Mills M, Rindfuss RR, McDonald P, te Velde E. ESHRE reproduction and society task force. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update. 2011;17:848–60. https://doi.org/10.1093/humupd/dmr026.
Article PubMed PubMed Central Google Scholar
Angarita AM, Johnson CA, Fader AN, Christianson MS. Fertility preservation: a key survivorship issue for young women with cancer. Front Oncol. 2016;6:102. https://doi.org/10.3389/fonc.2016.00102.
Article PubMed PubMed Central Google Scholar
Raymo JM, Park H, Xie Y, Yeung WJJ. Marriage and family in East Asia: continuity and change. Annu Rev Sociol. 2015;41:471–92. https://doi.org/10.1146/annurev-soc-073014-112428.
Article PubMed PubMed Central Google Scholar
Poorvu PD, Gelber SI, Zheng Y, Ruddy KJ, Tamimi RM, Peppercorn J, et al. Pregnancy after breast cancer: results from a prospective cohort of young women with breast cancer. Cancer. 2021;127:1021–8. https://doi.org/10.1002/cncr.33342.
Article CAS PubMed Google Scholar
Vriens IJH, Ter Welle-Butalid EM, de Boer M, de Die-Smulders CEM, Derhaag JG, Geurts SME, et al. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience. Breast Cancer Res Treat. 2020;181:77–86. https://doi.org/10.1007/s10549-020-05598-2.
Article CAS PubMed PubMed Central Google Scholar
Von Minckwitz G, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Eiermann W, et al. Response-guided neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2013;31:3623–30. https://doi.org/10.1200/JCO.2012.45.0940.
Omesi L, Narayan A, Reinecke J, Schear R, Levine J. Financial assistance for fertility preservation among adolescent and young adult cancer patients: a utilization review of the sharing Hope/LIVESTRONG fertility financial assistance program. J Adolesc Young Adult Oncol. 2019;8:554–9. https://doi.org/10.1089/jayao.2018.0151.
Peipert BJ, Hairston JC, McQueen DB, Hammond C, Feinberg EC. Increasing access to fertility care through private foundations. Fertil Steril. 2019;111:1211–6. https://doi.org/10.1016/j.fertnstert.2019.02.025.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, et al. Who are the women who enrolled in the POSITIVE trial: a global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. Breast. 2021;59:327–38. https://doi.org/10.1016/j.breast.2021.07.021.
Article PubMed PubMed Central Google Scholar
Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update. J Clin Oncol. 2018;36:2105–22. https://doi.org/10.1200/JCO.2018.77.8738.
Article CAS PubMed Google Scholar
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi.org/10.1038/bmt.2012.244.
Article CAS PubMed Google Scholar
Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36:1994–2001. https://doi.org/10.1200/JCO.2018.78.1914.
Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118:1710–7. https://doi.org/10.1002/cncr.26459.
Harada M, Osuga Y. Fertility preservation for female cancer patients. Int J Clin Oncol. 2019;24:28–33. https://doi.org/10.1007/s10147-018-1252-0.
Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376:2147–59. https://doi.org/10.1056/NEJMoa1612645.
Article CAS PubMed Google Scholar
Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019;380:617–28. https://doi.org/10.1056/NEJMoa1814017.
Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, et al. Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer (monarchE). J Clin Oncol. 2020;38:3987–98. https://doi.org/10.1200/JCO.20.02514.
Article CAS PubMed PubMed Central Google Scholar
Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382:810–21. https://doi.org/10.1056/NEJMoa1910549.
Article CAS PubMed Google Scholar
Kitano A, Shimizu C, Yamauchi H, Akitani F, Shiota K, Miyoshi Y, et al. Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists. ESMO Open. 2019;4: e000459. https://doi.org/10.1136/esmoopen-2018-000459.
Article PubMed PubMed Central Google Scholar
Peate M, Meiser B, Friedlander M, Zorbas H, Rovelli S, Sansom-Daly U, et al. It’s now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer—an Australian fertility decision aid collaborative group study. J Clin Oncol. 2011;29:1670–7. https://doi.org/10.1200/JCO.2010.31.2462.
Zebrack B. Information and service needs for young adult cancer patients. Support Care Cancer. 2008;16:1353–60. https://doi.org/10.1007/s00520-008-0435-z.
Ruggeri M, Pagan E, Bagnardi V, Bianco N, Gallerani E, Buser K, et al. Fertility concerns, preservation strategies and quality of life in young women with breast cancer: baseline results from an ongoing prospective cohort study in selected European Centers. Breast. 2019;47:85–92. https://doi.org/10.1016/j.breast.2019.07.001.
Comments (0)